| Symbol | IPLTF |
|---|---|
| Name | IMPLANTICA AG |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | - |
| Address | 9490 Liechtenstein Aeuelestrasse 45 |
| Telephone | +41 (0)79 335 09 49 |
| Fax | — |
| — | |
| Website | https://www.implantica.com/ |
| Incorporation | — |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: NASDAQ Stockholm |
| CIK | — |
| Description | Implantica AG is a medtech group providing effective care for serious health conditions and improving patients quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patients body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. To bring advanced technology into the body, and adequate energy supply is required which would require very large batteries, so, Implantica has developed a wireless energizing platform to supply energy to the body through intact skin. Additional info from OTC: |
No news found.